Target intelligence / Profile preview

Nitric oxide synthase 2 pseudogene 3 (NOS2P3)

Target
NOS2P3
Molecular classification
Pseudogene
01

Overview

Nitric oxide synthase 2 pseudogene 3 (NOS2P3) is a non-functional genomic sequence related to the inducible nitric oxide synthase gene (NOS2), located within the Smith-Magenis syndrome chromosome region. Pseudogenes such as NOS2P3 do not encode active enzymes or proteins and are typically transcriptionally silent, though some pseudogenes in other contexts have been implicated in the regulation of related gene expression through RNA interference or dominant-negative forms. For NOS2P3 specifically, there is no evidence of functional protein-coding capacity or direct involvement in human disease or therapeutics. Key Cautions: - Do not confuse NOS2 pseudogenes (such as NOS2P3) with their functional paralog, NOS2 (inducible nitric oxide synthase or iNOS), which does play significant biological and therapeutic roles. - If you are seeking information about functional nitric oxide synthases for therapeutic or pharmacological purposes, NOS2—not NOS2P3—should be investigated. Summary of Inaccuracies/Issues: - NOS2P3 is a pseudogene, not a biologically active molecule or therapeutic target. - It should not be used in place of or conflated with NOS2 or other genuine nitric oxide synthase proteins.

02

Mechanism of action

None applicable

03

Biological functions

Regulation of gene expressionOther

Beyond the preview

Go deeper on Nitric oxide synthase 2 pseudogene 3 (NOS2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitric oxide synthase 2 pseudogene 3 (NOS2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call